Platelet function in patients with Alzheimer disease: Analysis of 40 cases

National Medical Journal of China

Volumn 89, Issue 3, 2009, Pages 183-186

  Yu, Jie ^a   Jia, Jian Ping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; Nitric oxide; Nitric oxide synthase; Platelet aggregation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; MALE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TURBIDIMETRY; BLOOD; CASE CONTROL STUDY; CHEMISTRY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLATELET AGGREGATION;

EID: 77954837992     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.03.011     Document Type: Article

References (14)

1. Sevush S, Jy W, Horstman LL, et al. Platelet activation in Alzheimer disease. Arch Neurol, 1998,55:530-536.
2. Grammas P. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging, 2000,21:199-205. (Pubitemid 30387078)
3. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl Acad Sci USA, 1990,87:5193-5197.
4. Mehta JL, Chen LY, Kone BC, et al. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med, 1995,125:370-377.
5. Borroni B, Akkawi N, Martini G, et al. Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci, 2002,203-204:189-193.
6. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging, 2000,21:321-330. (Pubitemid 30387091)
7. Gentile MT, Vecchione C, Maff'ei A, et al. Mechanisms of soluble beta-amyloid impairment of endothelial function. J Biol Chem, 2004,279:48135-48142.
8. Randriamboavonjy V, Fleming I. Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there? Pharmacol Rep, 2005,57:59-65.
9. Weldon DT, Maggio JE, Mantyh PW. New insights into the neuropathology and cell biology oi Alzheimer' s disease. Geriatrics, 1997,52:S13-16.
10. Teunissen CE, de Vente J, Sleinbusch HW, et al. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging, 2002,23:485-508. (Pubitemid 34495461)
11. Elisa MK, Carolina DM, Isaias G, et al. Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol Aging, 2005,26:857-864.
12. Selley ML. Related Articles. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma ol patients with Alzheimer's disease. Neurobiol Aging, 2003,24:903-907.
13. Grammas P. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging, 2000,21:199-205. (Pubitemid 30387078)
14. Dorheim MA, Tracey WR, Pollock JS, et al. Nitric oxide synthase activity is elevated in brain microvcssels in Alzheimer's disease. Biochem Biophys Res Commun, 1994,205:659-665.